Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>
Kelly‐Anne Phillips(The University of Melbourne), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Michelle Cao, Liz Caldon(Garvan Institute of Medical Research), Heather Symecko(University of Pennsylvania), Lesley Andrews(Prince of Wales Hospital), Christian F. Singer(Comprehensive Cancer Center Vienna), Kelly Metcalfe(University of Toronto), Michael Friedländer(Prince of Wales Hospital), Jan Lubiński(Tumour Institute of Tuscany), John L. Hopper(The University of Melbourne), Leon Botes(Cancer Institute of New South Wales), William D. Foulkes(McGill University Health Centre), Yoland Antill(Peninsula Health), Ian Campbell(The University of Sydney), Roger L. Milne(The University of Melbourne), Melissa A. Brown(Oregon Health & Science University), Esther M. John, Irene L. Andrulis(University of Toronto), Nadine Tung(Beth Israel Deaconess Medical Center), Amber M. Aeilts(The Ohio State University), Jo Burke(Royal Prince Alfred Hospital), Anannya Chakrabarti, Michael Bogwitz(The Royal Melbourne Hospital), Manisha Chauhan(Garvan Institute of Medical Research), Raymond H. Kim(Steadman Philippon Research Institute), Simon Bodek(University Hospitals Bristol NHS Foundation Trust), Wanda Cui(The University of Melbourne), Mary Beth Terry(Columbia University Irving Medical Center), Susan M. Domchek(University City Science Center), Andrea Eisen(Sunnybrook Health Science Centre), Allison W. Kurian(Stanford University), Katherine L. Nathanson(Translational Therapeutics (United States)), Saundra S. Buys(University of Utah), David J. Amor(The University of Melbourne), Beth Y. Karlan(University of California, Los Angeles), Rosemary L. Balleine(The University of Sydney), Julie K. Bassett(Cancer Council Victoria), Joanne Kotsopoulos(Women's College Hospital), Steven A. Narod(Women's College Hospital), Melissa C. Southey(The University of Melbourne), Michael F. Buckley(New South Wales Department of Health), Jacek Gronwald(International Hereditary Cancer Center), Mary B. Daly(Fox Chase Cancer Center), Phyllis Butow(Garvan Institute of Medical Research), Deepa Chauhan(The University of Sydney), Ian Bennett, Meagan Brennan(The University of Queensland), Jonathan Beesley, James A. Chamberlain(Cancer Council Victoria)
Cited by 22
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k